Jeffrey Bailey
Director/Board Member chez ABRDN HEALTHCARE OPPORTUNITIES FUND
Fortune : - $ au 31/03/2024
Profil
Jeffrey Allen Bailey is currently the President & Director at Neurovance, Inc., the Director at Madison Vaccines, Inc., the Independent Director at Aurinia Pharmaceuticals, Inc., and an Independent Trustee at abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn World Healthcare Fund, and abrdn Healthcare Opportunities Fund.
Previously, he served as the Chief Executive Officer & Director at BioDelivery Sciences International, Inc., the President, Chief Executive Officer & Director at Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc., the Chief Executive Officer & Director at IlluminOss Medical, Inc., and the Chairman at Aileron Therapeutics, Inc. He also held positions at Johnson & Johnson, Landauer, Inc., ImaginAb, Inc., Biodelivery Systems, Inc., KP Pharmaceuticals LLC, Novartis Pharmaceuticals Corp., Fougera Pharmaceuticals, Inc., and Mainevest LLC.
Mr. Bailey obtained his undergraduate degree from Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/08/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jeffrey Bailey
| Sociétés | Poste | Début |
|---|---|---|
| ABRDN WORLD HEALTHCARE FUND | Director/Board Member | 01/01/2020 |
| ABRDN HEALTHCARE INVESTORS | Director/Board Member | 01/01/2020 |
| ABRDN LIFE SCIENCES INVESTORS | Director/Board Member | 01/01/2020 |
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Director/Board Member | 01/01/2020 |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | 18/08/2023 |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Director/Board Member | 27/10/2017 |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | President | 01/03/2017 |
Anciens postes connus de Jeffrey Bailey
| Sociétés | Poste | Fin |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chairman | 31/10/2023 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Chief Executive Officer | 22/03/2022 |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Bailey
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Landauer, Inc.
 Landauer, Inc. Information Technology ServicesTechnology Services Landauer, Inc. engages in the provision of radiation safety products and services. It offers dosimeters and radiation measurement and medical physics consulting and analytics services. It provides solutions for health care, medical, dental and veterinary, industry and energy and military and first responders. The company was founded by Robert S. Landauer Jr. in 1954 and is headquartered in Glenwood, IL. | Technology Services |
abrdn Healthcare Investors
 abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA. | Miscellaneous |
abrdn Life Sciences Investors
 abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA. | Miscellaneous |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
abrdn World Healthcare Fund
 abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Tekla World Healthcare Fund is a closed-end management investment company, which engages in investing in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities and debt securities. The company was founded on March 5, 2015 and is headquartered in Boston, MA. | Miscellaneous |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Health Technology |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
| Mainevest LLC | |
Madison Vaccines, Inc.
Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Health Technology |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Opportunities Fund operates as a closed-end investment fund and investment trust. The trust's investment objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Trust was founded on April 2, 2014 and is headquartered in Boston, MA. | Miscellaneous |
| Biodelivery Systems, Inc. |
